معرفی
Assoc. Prof. Dr. Mehmet Baysan is a faculty member in the Department of Computer Engineering at Istanbul Technical University (ITU), where he leads BaysanLab, focusing on computational genomics and bioinformatics. He holds a Ph.D. in Computer Science from The University of Texas at Dallas and completed postdoctoral training at the National Institutes of Health (NIH), specifically the National Cancer Institute. His academic journey includes research scientist roles at NYU Cancer Institute and Weill Cornell Medical College before returning to Turkey.
- B.S., Computer Engineering, Bilkent University (1999–2003)
- M.S. and Ph.D., Computer Science, The University of Texas at Dallas (2003–2008)
- Postdoctoral Fellow, National Cancer Institute, NIH (2010–2013)
Dr. Baysan's research lies at the intersection of computer science and genomics, with a strong emphasis on cancer genomics, bioinformatics pipeline development, and machine learning applications in biological data. His work involves integrating multi-omics datasets to improve cancer diagnosis and treatment strategies, particularly in glioblastoma and colorectal cancer. He has developed tools like COSAP for comparative sequencing analysis and VCF Observer for variant file inspection.
His recent publications (2023–2024) demonstrate sustained activity in somatic exome sequencing, genetic variant interpretation using tree-based models, and evaluation of NGS pipelines across different tumor microenvironments. These works appear in high-impact journals such as BMC Bioinformatics and Stresses, highlighting his contributions to methodological rigor and reproducibility in computational genomics.
Dr. Baysan has led multiple research projects funded by TTO, SRP, and TUSEB, including initiatives on spinal muscular atrophy diagnostics and cancer sequencing algorithm comparisons. While specific awards are not listed, his h-index of 11 and 393 citations reflect significant scholarly impact.
He mentors students through supervised research and advises on bioinformatics projects. His lab, BaysanLab, is actively involved in developing efficient and accurate sequencing analysis workflows, contributing to precision medicine. Collaborations span institutions like Istanbul University and involve interdisciplinary teams working on cancer and rare disease genomics.
